06-0.11 kg/m2) demonstrated 24-39% reductions of grain Cd.Evidence concerning exposure to air pollution and visual impairment is scarce. We evaluated the associations of ambient air pollution with visual impairment and visual acuity levels in Chinese schoolchildren. We recruited 61,995 children from 7 provinces/municipalities across China. Concentrations of air pollutants (i.e., particulate matter with an aerodynamic diameter of ≤ 1.0 µm [PM1], ≤ 2.5 µm [PM2.5], and 10 µm [PM10] as well as nitrogen dioxides [NO2]) were measured using machine learning methods. Visual acuity levels were measured using standard protocols. We used SAS PROC SURVEYLOGISTIC to assess the association between air pollution and visual impairment. An interquartile range increase in PM1, PM2.5, PM10, and NO2 was associated with a 1.133- (95% CI, 1.035-1.240), 1.267- (95% CI, 1.082-1.484), 1.142- (95% CI, 1.019-1.281), and 1.276-fold (95% CI, 1.173-1.388) increased odds of visual impairment, and the associations were stronger in children being boys, older, living in rural areas, and born to parents who had a lower educational level or smoked, compared to their counterparts. These results suggest that exposure to air pollution were positively associated with the odds of visual impairment, and the association may be modified by children's age, sex, and residential area as well as parental education level and cigarette smoking.Roxarsone (ROX), as one of aromatic organoarsenic compounds (AOCs), is extensively used in livestock industry, which tends to transform into high-toxic inorganic arsenic in environments. Herein, a bifunctional Co3O4-Y2O3, possessing extremely excellent catalytic and adsorption performance due to the synergy of Co3O4 and Y2O3, was designed and employed to activate peroxymonosulfate (PMS) for the elimination of ROX and the simultaneous in-situ adsorption of secondary inorganic arsenic, in which Co3O4 acted as the primary catalyst, and Y2O3 served as the main adsorbent. 50 μM (3.75 mg-As/L) of ROX was almost completely degraded, coupled with the conversion of As(III) to As(V) in the system of Co3O4-Y2O3 (0.2 g/L) and PMS (0.5 mM) within 15 min at initial pH 7. Meanwhile, > 99.3% of the secondary As(V) would be removed within 120 min. The reactive oxygen species (ROS) were identified to be •OH, SO4•-, and 1O2, which were responsible for the ROX degradation and the formation of As(V). Simultaneously, the produced As(V) were effectively adsorbed via the ligand/anion exchange with surface -OH and CO32- anions of Co3O4-Y2O3. The possible degradation pathways of ROX were further proposed on the basis of the intermediates identification. Our findings may provide an insight into the degradation of AOCs and the simultaneous removal of secondary inorganic arsenic via the PMS activation with Co3O4-Y2O3.It is an urgent need to develop environmentally friendly strategies with low energy consumption for gaseous formaldehyde (HCHO) purification. Herein, a sponge based MS/PDA/MnOx catalyst with plentiful 3D porosities was constructed. The dual-functional PDA layer not only promoted the MnOx loading (25 wt% MnOx in the composite), but also acted as a photothermal converter to absorb photo-irradiation to heat MnOx catalyst (~80 °C after 10 min irradiation). Moreover, the 3D network structure favored the mass transfer and effectively reduced the catalyst agglomeration to expose more active sites. As a result, the obtained MS/PDA/MnOx photothermocatalyst showed highly efficient performance for removal of HCHO within concentration of 40-320 ppm at room temperature under xenon light irradiation. This process followed a pseudo-second-order model, and the reaction rate of the MS/PDA/MnOx was 4.82 times of the MS/MnOx. Finally, a possible photothermocatalysis mechanism was proposed based on the intermediate examination via the in-situ DRIFTS investigation.Primary cilium is a microtubule-based organelle that projects from the surfaces of most mammalian cell types and protrudes into the extracellular milieu as an antenna-like sensor to senses extracellular physical and biochemical signals, and then transmits signals into cytoplasm or nucleus to regulate numerous physical and developmental processes. Therefore, loss of primary cilia is associated to multiple cancer progression, including skin, breast, pancreas, ovarian, prostate, and kidney cancers. Our previous studies demonstrate that high prevalent loss of DAB2 Interacting Protein (DAB2IP) is associated with renal cell carcinoma, and we found a kinesin-like protein, kinesin family member 3A (KIF3a), was significantly increased in DAB2IP-interacting protein fraction. KIF3 is one of the most abundant kinesin-2 family proteins expressed in cells, and it is necessary for ciliogenesis. In this study, we observed that loss of DAB2IP in normal kidney epithelial cell significantly impair primary cilia formation. We unveiled a new mechanism of primary cilia stability via DAB2IP and KIF3a physical interaction at DAB2IP-PH domain. Furthermore, we found that KIF3a also act as a tumor suppressor in renal cell carcinoma, affect tumor development and patient survival.
  COVID-19 is a multi-system infection which predominantly affects the respiratory system, but also causes systemic inflammation, endothelialitis and thrombosis. The consequences of this include renal dysfunction, hepatitis and stroke. In this systematic review, we aimed to evaluate the epidemiology, clinical course, and outcomes of patients who suffer from stroke as a complication of COVID-19.
 
  We conducted a systematic review of all studies published between November 1, 2019 and July 8, 2020 which reported on patients who suffered from stroke as a complication of COVID-19.
 
  326 studies were screened, and 30 studies reporting findings from 55,176 patients including 899 with stroke were included. The average age of patients who suffered from stroke as a complication of COVID-19 was 65.5 (Range 40.4-76.4 years). The average incidence of stroke as a complication of COVID-19 was 1.74% (95% CI 1.09% to 2.51%).  https://www.selleckchem.com/products/ag-221-enasidenib.html  The average mortality of stroke in COVID-19 patients was 31.76% (95% CI 17.77% to 47.31%). These patients also had deranged clinical parameters including deranged coagulation profiles, liver function tests, and full blood counts.